ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts (2006) 12 P132

Thyroid eye disease in patients treated with radio-iodine

M Banerjee, J Hill & A Lakhdar

Lancashire Teaching Hospitals NHS Trust, Preston, United Kingdom.


Rapid induction of eu/hypothyroidism in patients with immune hyperthyroidism has been known to precipitate Thyroid eye disease (TED). Our aim was to investigate the incidence of TED in patients treated with radio-iodine therapy (RIT) at our hospital.


We examined case notes of 45 patients who underwent radio-iodine therapy for Graves’ disease with 544.7 (95% CI- 522.3 – 567.1) MBq between June 1999 and June 2002. None of these patients had received steroids prior to RIT.


45 patients with Graves’ disease (age – 48.02, 95% CI-44.02–52.03 years, 84.4% female) were studied. They had a follow-up period of 8.1 (6.1–10.1) months following RIT. 17.8% of patients had TED prior to and 8.9% had TED after having RIT. 2.2% of these patients had pre-existing TED which worsened after RIT. On adjusting for age at RIT administration, first follow up since RIT and duration of follow-up, the initial duration of medical therapy was found to influence both prevalence of TED (Beta −0.006, 95% CI- 0.001–0.011, P=0.03) as well as post RIT incidence of TED (Beta −0.004, 95% CI- 0.001–0.007, P=0.02) while first detection of eu/hypothyroidism since RIT influenced incidence of TED as well (Beta −0.03, 95% CI- 0.00–0.06, P=0.05).


TED is common both prior to and after RIT in patients with Graves’ disease. Rapid development of eu/hypothyroidism is associated with incidence of post-RIT TED. Earlier institution of and use of steroids prior to RIT may decrease the incidence and prevalence of TED in these patients.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts